- Abstract
Vortioxetine is approved for the treatment of adults with major depressive disorder. This open-label extension (OLE) study evaluated the safety and tolerability of vortioxetine in the long-term treatment of major depressive disorder patients, as well as evaluated its effectiveness using measures of depression, anxiety, and overall functioning.
Paula L. Jacobsen et al., Int Clin Psychopharmacol. 2015 Sep; 30(5): 255–264.
Published online 2015 Aug 4. doi: 10.1097/YIC.0000000000000081